Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Everyday Health, Inc. (EVDY)
|
Add to portfolio |
|
|
|
| Price: |
$6.05
| | Metrics |
| OS: |
33.8
|
M
| |
-15
|
% ROE
|
| Market cap: |
$204
|
M
| |
-27
|
% ROIC
|
|
Net debt:
|
$92.4
|
M
| |
12.2
|
x Debt/EBITDA
|
|
EV:
|
$297
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$7.6
|
M
| |
39.1
|
x EV/EBITDA
|
|
EBIT
|
($14.8)
|
M
| |
|
|
| EPS |
($0.71)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 232.0 | 184.3 | 155.9 | 138.5 | 125.8 | 90.1 | 69.4 | 47.4 |
| Revenue growth | 25.9% | 18.3% | 12.5% | 10.1% | | 29.8% | 46.6% | |
| Cost of goods sold | 66.9 | 49.3 | 43.3 | 40.5 | -41.0 | 39.5 | 35.2 | 30.1 |
| Gross profit | 165.1 | 135.0 | 112.5 | 97.9 | 166.8 | 50.7 | 34.2 | 17.3 |
| Gross margin | 71.2% | 73.3% | 72.2% | 70.7% | 132.6% | 56.2% | 49.2% | 36.4% |
| Sales and marketing | 74.8 | 48.6 | 44.4 | 38.6 | 36.3 | 20.8 | 14.5 | 7.4 |
| Research and development | 55.9 | 44.5 | 43.8 | 45.7 | 37.0 | 20.2 | 14.9 | 10.8 |
| General and administrative | 39.5 | 30.0 | 27.5 | 25.9 | 23.2 | 16.2 | 12.9 | 6.9 |
| EBITA | 1.0 | 14.4 | 0.5 | -8.4 | -11.6 | -16.4 | -12.4 | -9.8 |
| EBITA margin | 0.4% | 7.8% | 0.3% | -6.1% | -9.3% | -18.2% | -17.9% | -20.7% |
| Amortization of intangibles | 6.1 | 2.5 | 3.6 | 3.8 | | | | |
| EBIT | -5.1 | 11.8 | -3.1 | -12.2 | -11.6 | -16.4 | -12.4 | -9.8 |
| EBIT margin | -2.2% | 6.4% | -2.0% | -8.8% | -9.3% | -18.2% | -17.9% | -20.7% |
| Pre-tax income | -10.3 | 4.0 | -11.9 | -18.2 | -13.2 | -17.7 | -12.9 | -10.1 |
| Income taxes | 1.3 | -8.7 | 1.1 | 1.0 | -0.6 | 1.3 | 0.3 | 0.0 |
| Tax rate | | | | | 4.6% | | | 0.0% |
| Earnings from continuing ops | -11.6 | 4.6 | -18.2 | -25.7 | -12.6 | -19.0 | -13.2 | -10.1 |
| Earnings from discontinued ops | | | | 3.3 | -2.6 | | | |
| Net income | -11.6 | 4.6 | -18.2 | -22.5 | -15.2 | -19.0 | -13.2 | -10.1 |
| Net margin | -5.0% | 2.5% | -11.7% | -16.2% | -12.1% | -21.1% | -19.0% | -21.4% |
| |
| Diluted EPS | ($0.36) | $0.17 | ($3.57) | ($5.37) | ($2.74) | ($2.89) | ($2.01) | ($1.57) |
| Shares outstanding (diluted) | 32.0 | 26.9 | 5.1 | 4.8 | 4.6 | 6.6 | 6.6 | 6.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|